Crenezumab Biosimilar - Anti-APP,Amyloid beta mAb - Research Grade, Human Humanized, Monoclonal
Artikelnummer:
PTG-PX-TA1269-1MG
- Bilder (0)
| Artikelname: | Crenezumab Biosimilar - Anti-APP,Amyloid beta mAb - Research Grade, Human Humanized, Monoclonal |
| Artikelnummer: | PTG-PX-TA1269-1MG |
| Hersteller Artikelnummer: | PX-TA1269-1MG |
| Alternativnummer: | PTG-PX-TA1269-1MG |
| Hersteller: | ProteoGenix |
| Wirt: | Human Humanized |
| Kategorie: | Antikörper |
| Spezies Reaktivität: | Human |
| Alternative Synonym: | Anti-APP, Anti-Amyloid beta, MABT5102A, RG7412, CAS: 1095207-05-8 |
| Klonalität: | Monoclonal |
| UniProt: | P05067 |
| Puffer: | 0.01M PBS, pH 7.4. |
| Expression System: | Eukaryotic expression |
| Target-Kategorie: | APP/Amyloid beta |
Produktgarantie und fachkundiger Support
